Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar

NCT02546492 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT02546492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02546492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2016
Completion date
May 27, 2021
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

transplant glomerulopathy